来自官方财务报表的收入、利润与现金流历史。
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage.
| 利润表 | TTM → 2026-07-31 | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 | 2017-10-31 | 2016-10-31 | 2015-10-31 | 2014-10-31 | 2013-10-31 | 2012-10-31 | 2011-10-31 | 2010-10-31 | 2009-10-31 | 2008-10-31 | 2007-10-31 | 2006-10-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 总收入 | $4.2B | $4.1B | $3.9B | $3.6B | $3.3B | $2.9B | $2.4B | $2.7B | $2.5B | $2.1B | $2.0B | $1.8B | $1.7B | $1.6B | $1.4B | $1.3B | $1.2B | $1.1B | $1.1B | $951M | $859M |
| 毛利 | $2.7B | $2.5B | $2.6B | $2.4B | $2.1B | $2.0B | $1.5B | $1.8B | $1.6B | $1.4B | $1.2B | $1.1B | $1.1B | $1.0B | $924M | $805M | $677M | $596M | $610M | $520M | $526M |
| 毛利率% | 64.7% | 60.7% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% | 66.2% | 64.5% | 63.8% | 59.6% | 59.6% | 63.5% | 64.7% | 63.9% | 60.5% | 58.4% | 55.2% | 57.4% | 54.6% | 61.2% |
| 营业利润（EBIT） | $544M | $683M | $706M | $533M | $508M | $506M | $312M | $547M | $403M | $429M | $324M | $237M | $306M | $306M | $283M | $228M | $190M | $150M | $127M | $46M | $113M |
| 营业利润率% | 12.8% | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% | 20.1% | 16.5% | 13.2% | 17.8% | 19.3% | 19.6% | 17.1% | 16.4% | 13.9% | 11.9% | 4.8% | 13.1% |
| 净利 | $571M | $375M | $392M | $294M | $386M | $2.9B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | $296M | $248M | $175M | $113M | $101M | $65M | ($11M) | $66M |
| 净利润率 % | 13.5% | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% | 11.3% | 15.7% | 18.6% | 17.2% | 13.2% | 9.7% | 9.3% | 6.2% | -1.2% | 7.7% |
| EBITDA | — | $1.1B | $1.1B | $886M | $879M | $824M | $590M | $826M | $690M | $616M | $520M | $425M | $443M | $447M | $398M | $308M | $255M | $252M | $209M | $140M | $181M |
| 每股收益（EPS） | $2.93 | $1.87 | $1.96 | $1.48 | $1.94 | $14.77 | $1.20 | $2.33 | $0.70 | $1.88 | $1.40 | $1.03 | $1.38 | $1.49 | $1.26 | $0.91 | $0.61 | $0.55 | $0.35 | $-0.06 | $0.35 |
| 已发行股数 (M) | — | 200M | 200M | 199M | 199M | 199M | 198M | 200M | 199M | 198M | 196M | 197M | 196M | 199M | 197M | 193M | 186M | 182M | 187M | 179M | 190M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 COO 交互式查看器。 /companies/us/COO
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms